Two cryo-EM studies built 5-HT2A agonists that actively antagonise 5-HT2B.
Comparing the binding pockets of the two receptors gave design rules — steric and conformational constraints in the side-extended and extended pockets — that were then used to make tryptamine and phenethylamine derivatives with the split profile. Selected compounds, including IHCH-2330, showed antidepressant-like effects in rodents.